Results 161 to 170 of about 768,450 (337)

A Microphysiological Interface of Skeletal Myobundles and Inflamed Adipose Tissue for Recapitulating Muscle Dysfunction in an Obese Microenvironment

open access: yesAdvanced Healthcare Materials, EarlyView.
A human cell‐based microphysiological system integrates engineered muscle tissues with an inflamed adipose–macrophage niche to model obese microenvironment‐induced muscle dysfunction. Muscle contraction is quantified by pillar deflection coupled with computational stiffness estimation. Secretome and transcriptomic profiling reveal inflammation‐mediated
Seunggyu Kim   +16 more
wiley   +1 more source

CLOSE RELATIONSHIP OF CAROTID INTIMA-MEDIA THICKNESS WITH LEFT VENTRICULAR HYPERTROPHY AND EJECTION FRACTION IN END-STAGE RENAL DISEASE PATIENTS UNDERGOING HEMODIALYSIS TREATMENT [PDF]

open access: yes, 2011
Background- Two principal findings of cardiovascular disease in end-stage renal disease patients undergoing regular hemodialysis are left ventricular hypertrophy (LVH) and arterial disease due to rapidly progressive atherosclerotic vascular disease ...
Baradaran, Azar.   +2 more
core  

Electrochemical Biosensor for Rapid Detection of Acute Rejection in Kidney Transplants

open access: yesAdvanced Healthcare Materials, EarlyView.
A low‐cost, rapid electrochemical immunosensor coated with a novel antifouling nanocomposite enables single‐step, dual‐biomarker profiling directly from unprocessed urine. Application in a clinical study shows accurate discrimination of acute rejection in kidney transplants from other acute kidney injuries via machine learning.
Rohit Gupta   +9 more
wiley   +1 more source

Body Biofluids for Minimally‐Invasive Diagnostics: Insights, Challenges, Emerging Technologies, and Clinical Potential

open access: yesAdvanced Healthcare Materials, EarlyView.
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao   +2 more
wiley   +1 more source

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.

open access: yesKidney International, 1995
R. Foley   +12 more
semanticscholar   +1 more source

Life Experiences of Patients Suffering End Stage Renal Disease [PDF]

open access: yes, 2013
Introduction: Haemodialysis (HD) is one of therapies to sustain life for people with End Stage Renal Disease (ESRD). HD and ESRD are the source of the stressor for the patients.
Bakar, A. (Abu)   +6 more
core  

Multivalent Protein Nanorings for Broad and Potent SARS‐CoV‐2 Neutralization

open access: yesAdvanced Healthcare Materials, EarlyView.
A protein‐only, modular multivalent nanoscaffold displaying 20 anchor points, decorated with two different binders (10 of each), targeting the SARS‐CoV‐2 receptor‐binding domain is presented. The construct self‐assembles into stable, biocompatible, homogeneous nanoparticles, exhibit synergistic binding with fM IC50 values. It also detects spike at 9 ng 
Molood Behbahanipour   +11 more
wiley   +1 more source

INFLAMMATORY MARKERS IN END-STAGE RENAL DISEASE PATIENTS ON HAEMODIALYSIS

open access: diamond, 2020
Phebe L. Abdel-Messeih   +3 more
openalex   +2 more sources

Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.

open access: yesJournal of the American Medical Association (JAMA), 2014
J. Coresh   +26 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy